Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.160
-0.030 (-1.37%)
At close: May 15, 2026, 4:00 PM EDT
2.150
-0.010 (-0.46%)
After-hours: May 15, 2026, 6:16 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $33.42 million as of May 15, 2026. Its market cap has decreased by -10.09% in one year.
Market Cap
33.42M
Enterprise Value
14.75M
1-Year Change
-10.09%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $33.42M, a decrease of -61.67%. That is a compound annual growth rate of -6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 33.42M | -37.57% |
| Dec 31, 2025 | 53.54M | 41.18% |
| Dec 31, 2024 | 37.92M | 39.61% |
| Dec 29, 2023 | 27.16M | 21.53% |
| Dec 30, 2022 | 22.35M | -59.95% |
| Dec 31, 2021 | 55.80M | 77.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 35.20M |
| NextCure | 35.14M |
| Pluri | 33.87M |
| Veru Inc. | 33.87M |
| Boundless Bio | 33.58M |
| Tevogen Bio Holdings | 33.11M |
| Apollomics | 32.94M |
| Evaxion | 32.69M |